Relevant bibliographies by topics / Contraceptives

Contents

  1. Journal articles
  2. Dissertations / Theses
  3. Books
  4. Book chapters
  5. Conference papers
  6. Reports

Academic literature on the topic 'Contraceptives'

Author: Grafiati
Published: 4 June 2021
Last updated: 31 July 2024

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the lists of relevant articles, books, theses, conference reports, and other scholarly sources on the topic 'Contraceptives.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Journal articles on the topic "Contraceptives"

1

David, Luiza Ortiz, and Sheldon Rodrigo Botogoski. "SARC e LARC: grau de conhecimento e frequência de uso em complexo hospitalar de referência no Paraná / SARC and LARC: degree of knowledge and frequency of use in a reference hospital complex in Paraná." Arquivos Médicos dos Hospitais e da Faculdade de Ciências Médicas da Santa Casa de São Paulo 66, no. 1u (May 26, 2021): 1. http://dx.doi.org/10.26432/1809-3019.2021.66.016.

Full text
Abstract:
Introdução: Contraceptivos representam um elemento essencial para a vida reprodutiva e para o planejamento familiar. O grau de conhecimento das mulheres sobre esse tema exerce influência sobre suas escolhas por determinados métodos anticoncepcionais. Objetivos: os objetivos deste estudo foram traçar o perfil etário e socioeconômico das pacientes do Ambulatório de Reprodução Humana do CHC-UFPR e avaliar seu conhecimento e uso de contraceptivos de curta e de longa ação (SARC e LARC), de forma a identificar lacunas de informação que pudessem ocasionargestações não planejadas e direcionar futuras estratégias educativas sobre contraceptivos. Métodos: Conduzimos entrevistas por meio de questionários objetivos aplicados a pacientes do sexo feminino entre 18 e 50 anos na ocasião de suas consultas, indagando-as sobre sua ciência da existência de diversos anticoncepcionais, tipo de método utilizado e tempo de uso, presença, frequência e motivos para gestações não planejadas. Resultados: Os principais resultados indicaram um grupo de pacientes jovens e com alta escolaridade, cuja utilização de métodos anticoncepcionais era semelhante entre SARC e LARC. O conhecimento dos anticoncepcionais foi satisfatório, principalmente entre os mais populares como anticoncepcional hormonal oral e DIU de cobre. Gestações não planejadas estiveram presentes na vida reprodutiva de 60% das pacientes, sendo o principal motivo o não uso de contraceptivos. Não houve associação entre uso de SARC ou LARC e maior número de gestações indesejadas. O número de contraceptivos conhecidos por mulheres sem gestações indesejadas foi uma mediana maior do que aquele das mulheres com esses eventos. Conclusão: A abordagem das pacientes do ambulatório da Reprodução Humana do CHC-UFPR deve ser direcionada para pacientes jovens, com alto grau de instrução e amplo conhecimento sobre contraceptivos. É importante que os profissionais de saúde do local busquem orientá-las de forma a reduzir a taxa de gestações não planejadas.Palavras chave: Anticoncepcionais, gravidez não planejada, ConhecimentoABSTRACT Introduction: Contraceptive agents represent an essential element in reproductive life and family planning. The knowledge extension for women about that subject influences choices for certain contraceptive methods. Objective: The aims of this study were to determine the age and socioeconomic profile of the patients of the Human Reproduction Clinic in the Hospital Complex of Federal University of Paraná and to evaluate their knowledge and use of short-acting reversible contraceptives (SARC) and long-acting reversible contraceptives (LARC), in order to idenfity information gaps that could cause unplanned pregnancies and direct future educational strategies on contraceptives. Methodology: We conducted interviews using objective questionnaires applied to female patients aged from 18 to 50 years old before or after their medical appointment, asking about their knowledge of the existence of diverse contraceptive agents, type of contraceptive utilized and duration of use, presence, number and reasons for unplanned pregnancies. Results: The main results indicated that the group was mostly young and highly educated, utilizing SARC and LARC in similar frequencies. The knowledge of the existence of the contraceptive agents was satisfactory and the most popular methods were the contraceptive pill and the Coopper IUD. Unplanned pregnancies were present in the reproductive life of 60% of the patients and the most common reasons for these events was the non use of contraceptives. There was no association between the use of SARC or LARC and a higher number of unplanned pregnancies. The number of contraceptives known by women without previous history of unintended pregnancy was a median higher than those of women with those events. Conclusion: Hereafter, the approach to patients in the Human Reproduction Clinic in the Hospital Complex of Federal University of Paraná should be directed to young and highly educated women, with broad knowledge about contraceptive agents. It is important that health professionals of the clinic guide patients aiming to reduce the local unplanned pregnancy rates.Keywords: Contraceptive agents, Unplanned pregnancy, Knowledge
APA, Harvard, Vancouver, ISO, and other styles
2

Akter, Dr Aliza, Dr Umme Shaila, Dr Rashed Md Sharif, and Dr Sadia Israt Zaman. "The Relationship between Hormonal Contraceptives and Metabolic Syndrome." Scholars Journal of Applied Medical Sciences 10, no. 3 (March 30, 2022): 375–79. http://dx.doi.org/10.36347/sjams.2022.v10i03.017.

Full text
Abstract:
Background: Metabolic syndrome (MS) in women using hormonal contraceptives (HCs) are common health hazards all over the world than that of contraceptives non users. Objective: To observe the relationship of hormonal contraceptives with metabolic syndrome. Method: This cross-sectional study was carried out in the Department of Physiology, Dhaka Medical College Hospital, Dhaka, during the period from January to 31 December, 2011. Two hundred women age ranged 20-35 years using hormonal contraceptives were included in this study group. The study group was subdivided into oral contraceptive users (Group B) and injectable contraceptive users (Group C). All the women using hormonal contraceptive were selected from Model clinic and Medicine ward in DMC and also from different areas of Dhaka city. Results: In this study, the BMI value in both oral and injectable contraceptives users were significantly (P<0.001) higher than that of contraceptive non users. Within the study groups, the BMI in oral and injectable contraceptives users for 1-5 years were significantly lower (P<0.001) than that of oral contraceptive users for 6-10 years. The waist circumference (WC) in all oral and injectable contraceptives users for 1-5 years and 6-10 years were significantly (P<0.001) higher than that of contraceptive non users. Conclusion: Percentage of distribution of subjects having metabolic syndrome was higher in women using hormonal contraceptives and increase duration of hormonal contraceptives use progressively increase the level of parameters of metabolic syndrome. So, it may be concluded that women using hormonal contraceptives are more prone to develop metabolic syndrome.
APA, Harvard, Vancouver, ISO, and other styles
3

Lima, Adman Câmara Soares, Larissa Castelo Guedes Martins, Marcos Venícios de Oliveira Lopes, Thelma Leite de Araújo, Francisca Elisângela Teixeira Lima, Priscila de Souza Aquino, and Escolástica Rejane Ferreira Moura. "Influence of hormonal contraceptives and the occurrence of stroke: integrative review." Revista Brasileira de Enfermagem 70, no. 3 (June 2017): 647–55. http://dx.doi.org/10.1590/0034-7167-2016-0056.

Full text
Abstract:
ABSTRACT Objective: To identify scientific evidence regarding the influence of hormonal contraceptive use and the occurrence of stroke. Method: Integrative review of the literature, through database search using the descriptors "contraceptive agents", "contraceptive devices", "contraceptives, Oral" and "Stroke". Original studies in Portuguese, Spanish and English, published in full and available online were included. Studies that did not answer our guiding questions and duplicated studies were excluded. Results: Women using combined oral contraceptives have higher risk of stroke, even with a lower hormonal dosage and different types of progestogen, regardless of the duration of use. The use of contraceptives associated with smoking, hypertension, migraine, hypercholesterolemia, obesity and sedentary lifestyle increases the chance of stroke. Contraceptive patch and vaginal ring are associated to increased risk. Conclusion: Use of combined hormonal contraceptives, except for the injectable and the transdermal ones, increases the chance of occurrence of the event. Progestogen-only contraceptives were considered safe.
APA, Harvard, Vancouver, ISO, and other styles
4

Anis, Wahyul, Erni Rosita Dewi, Renata Alya Ulhaq, Shrimarti Rukmini Devy, Budi Prasetyo, Diah Indriani, and Kasiati. "Use of contraceptives in a high-income population: a cross-sectional study in Indonesia." British Journal of Midwifery 31, no. 9 (September 2, 2023): 496–501. http://dx.doi.org/10.12968/bjom.2023.31.9.496.

Full text
Abstract:
Background/Aims The Indonesian family planning programme promotes contraceptive use to control population density. Counselling is widely used to improve contraceptive use. The aim of this study was to explore women's use of contraceptives before and after counselling. Methods This cross-sectional study collected data from 10 790 women across 10 districts/cities in East Java. The data obtained were analysed using descriptive statistical analysis and paired t-tests. Results After counselling, use of contraceptives increased significantly (P<0.001), from 75.8% using contraceptives before counselling to 99.98% using them after counselling. Use of the contraceptive pill notably increased from 16.7% to 40.9%. Conclusions Short-term contraceptives were most popular with women in this population. Counselling can contribute to increased use of long-term contraceptive methods.
APA, Harvard, Vancouver, ISO, and other styles
5

Gunardi, Eka Rusdianto, Denny Khusen, and Kevin Winston. "The Role of Contraception in the Past, Present and Future." Journal Of The Indonesian Medical Association 68, no. 8 (September 25, 2019): 395–400. http://dx.doi.org/10.47830/jinma-vol.68.8-2018-50.

Full text
Abstract:
Contraceptives play an undeniable important role in woman’s lives. It is widely accepted that the availability of both hormonal and non-hormonal modern contraceptives have improved 0 women’s lives worldwide by allowing women to control their own fertility. Indirectly, contraceptives have been shown to reduce maternal mortality, unwanted pregnancy, and overpopulation. However, the contraceptives available today may not be suitable for all users. Furthermore, there is still need to expand available current contraceptives choices especially long-term contraceptives in order to improve acceptability. As a result, several novel products such as implants, contraceptive vaginal rings, and transdermal patches have recently been introduced in family planning programs. Additional issue of contraceptive needed to be addressed is the adverse effects of hormonal contraceptives. Therefore, new combinations with an improved metabolic profile is currently being researched. Generally, the introduction of new methods with additional health benefits and less side effects would help women with their unmet needs to obtain access to a wider range of contraceptives.
APA, Harvard, Vancouver, ISO, and other styles
6

Tshitenge, S. T., K. Nlisi, V. Setlhare, and R. Ogundipe. "Knowledge, attitudes and practice of healthcare providers regarding contraceptive use in adolescence in Mahalapye, Botswana." South African Family Practice 60, no. 6 (November 30, 2018): 39. http://dx.doi.org/10.4102/safp.v60i6.4928.

Full text
Abstract:
Introduction: Adolescent pregnancy is a global public health problem, for which healthcare providers (HCPs) play a critical role to prevent unintended pregnancy. This study investigated the knowledge, attitude and practice (KAP) of HCPs towards the use of contraceptives in adolescents.Results: Of the 101 eligible for the study, 79.2% HCPs from the selected clinics and hospital responded. The majority (91.2%) of respondents felt confident to explain to adolescents how to use old contraceptive methods such as oral contraceptives or IUCD, less than half of the respondents (41.3%) were confident to explain how to use new contraceptive methods such as transdermal contraceptive patches or vaginal rings. Medical doctors felt more confident to prescribe new contraceptive methods compared with nurses, both vaginal rings (p-value = 0.0006) and transdermal contraceptive patches (p-value = 0.0003). More than two-thirds of the respondents disagreed that beliefs influenced their ability to offer contraceptive services to adolescents, half of the respondents strongly disagreed that it was morally wrong for adolescents to use contraceptives. Although three-quarters of respondents strongly agreed (median = 5, [IQR 5–6]) that they were comfortable with prescribing contraceptives to adolescents, only 23% of the respondents very much prescribed or always prescribed contraceptives to adolescents.Conclusion: Most of the HCPs prescribed contraceptives irregularly, and had limited knowledge about newer methods. To change HCPs’ KAP, in addition to continuing medical education (CME), the establishment of family planning clinics for adolescents and more undergraduate contraceptive teaching for medical and nursing students could result in the increased utilisation of contraceptive services by adolescents.
APA, Harvard, Vancouver, ISO, and other styles
7

Jalalvandi, Esmat, Hafez Jafari, Christiani A. Amorim, Denise Freitas Siqueira Petri, Lei Nie, and Amin Shavandi. "Vaginal Administration of Contraceptives." Scientia Pharmaceutica 89, no. 1 (December 25, 2020): 3. http://dx.doi.org/10.3390/scipharm89010003.

Full text
Abstract:
While contraceptive drugs have enabled many people to decide when they want to have a baby, more than 100 million unintended pregnancies each year in the world may indicate the contraceptive requirement of many people has not been well addressed yet. The vagina is a well-established and practical route for the delivery of various pharmacological molecules, including contraceptives. This review aims to present an overview of different contraceptive methods focusing on the vaginal route of delivery for contraceptives, including current developments, discussing the potentials and limitations of the modern methods, designs, and how well each method performs for delivering the contraceptives and preventing pregnancy.
APA, Harvard, Vancouver, ISO, and other styles
8

Williams, Jennifer S., and Maureen J. MacDonald. "Influence of hormonal contraceptives on peripheral vascular function and structure in premenopausal females: a review." American Journal of Physiology-Heart and Circulatory Physiology 320, no. 1 (January 1, 2021): H77—H89. http://dx.doi.org/10.1152/ajpheart.00614.2020.

Full text
Abstract:
Hormonal contraceptives are one of the most widely used prescriptions for premenopausal women worldwide. Although the risk of venous and arterial cardiovascular events (e.g., deep vein thrombosis, arterial clotting) with hormonal contraceptives, specifically oral contraceptive pills, has been established, the literature on early risk indicators, such as peripheral vascular structure and function has yet to be consolidated. The purpose of this review is to summarize literature examining the impact of different hormonal contraceptives on vascular function and structure, including consideration of phasic differences within a contraceptive cycle, and to propose future directions for research. It is evident that hormonal contraceptive use appears to impact both macrovascular and microvascular endothelial function, with phasic differences in some contraceptive types dependent on progestin type, the ratio of ethinyl estradiol-to-progestin, and route of administration. However, hormonal contraceptives do not appear to impact smooth muscle function in the macrovasculature or microvasculature, arterial stiffness, or vascular structure. Underlying mechanisms for observed impacts and areas of future research are discussed. This review provides timely consolidation of research examining hormonal contraceptives and peripheral vascular function and structure and provides guidance on considerations for hormonal contraceptive use in study design.
APA, Harvard, Vancouver, ISO, and other styles
9

Cano Andrade, Ricardo Andres. "Legal-dogmatic controversies between civil law and criminal law: the case of the exercise of the right of possession in Colombia." Sociology International Journal 7, no. 4 (August 7, 2023): 193–201. http://dx.doi.org/10.15406/sij.2023.07.00343.

Full text
Abstract:
Women’s unmet need of modern contraceptive in Cameroon has many gender specific health risks and development implications. This paper sought to examine the perceptions variation among men and women towards contraceptive use by employing a mixed method design to collect both quantitative and qualitative data from 248 participants using questionnaires and interview guides. The results showed that 86% of the participants had heard of contraceptives and a lesser proportion (8%) did not know the importance of contraceptives; 67% of respondents indicated that women were in greater need of contraceptives as opposed to 33 % who opined that men needed contraceptives and the relationship between gender perception and contraception use was statistically significant (p-value=0.04). This study contributes to the body of knowledge on contraceptive use and the predictors which may account for its weak uptake and the wide unmet need of contraceptives in African countries like Cameroon.
APA, Harvard, Vancouver, ISO, and other styles
10

Mbihbiih, Niying Roger. "Perception variation on contraceptive use in the Bamenda and Buea communities in Cameroon." Sociology International Journal 7, no. 4 (August 14, 2023): 203–9. http://dx.doi.org/10.15406/sij.2023.07.00344.

Full text
Abstract:
Women’s unmet need of modern contraceptive in Cameroon has many gender specific health risks and development implications. This paper sought to examine the perceptions variation among men and women towards contraceptive use by employing a mixed method design to collect both quantitative and qualitative data from 248 participants using questionnaires and interview guides. The results showed that 86% of the participants had heard of contraceptives and a lesser proportion (8%) did not know the importance of contraceptives; 67% of respondents indicated that women were in greater need of contraceptives as opposed to 33 % who opined that men needed contraceptives and the relationship between gender perception and contraception use was statistically significant (p-value=0.04). This study contributes to the body of knowledge on contraceptive use and the predictors which may account for its weak uptake and the wide unmet need of contraceptives in African countries like Cameroon.
APA, Harvard, Vancouver, ISO, and other styles
More sources

Dissertations / Theses on the topic "Contraceptives"

1

Ferreira, Jéssica Mayra 1988. "Razões para a troca de diferentes contraceptivos para contraceptivos reversíveis de longa duração entre mulheres brasileiras = Reasons for Brazilian women to switch from different contraceptives to long-acting reversible contraceptives." [s.n.], 2013. http://repositorio.unicamp.br/jspui/handle/REPOSIP/312837.

Full text
Abstract:
Orientador: Luis Guillermo Bahamondes
Dissertação (mestrado) - Universidade Estadual de Campinas, Faculdade de Ciências Médicas
Made available in DSpace on 2018-08-24T12:55:50Z (GMT). No. of bitstreams: 1 Ferreira_JessicaMayra_M.pdf: 1683051 bytes, checksum: d85c69881bfcbb72838041d2f09bb2c1 (MD5) Previous issue date: 2013
Resumo: Objetivos: conhecer as razões referidas pelas mulheres que trocaram seus métodos anticonceptivos (MAC) para um método contraceptivo reversível de longa duração (Long Acting Reversible Contraceptives ¿ LARC) e avaliar sua satisfação através da taxa de continuação. Métodos: Mulheres entre 18 e 50 anos de idade usando diferentes MACs que desejavam mudar para um LARC responderam a um questionário abrangendo suas motivações para trocarem seus atuais métodos. O tamanho amostral foi calculado em 1.040 mulheres. O desempenho clínico e a taxa de continuação foram avaliados por tabela de vida até um ano após o início do uso do LARC. A data limite para análise foi 23 de maio de 2013. Resultados: Do total de 1.167 entrevistadas, foram avaliados os dados de 1154 mulheres. A principal razão pessoal para a troca de contraceptivos foi o medo de engravidar enquanto que as principais razões médicas foram náusea e vômito e anormalidades no fluxo menstrual. Nenhuma gravidez ocorreu durante o uso dos LARCs e as principais causas para descontinuação foram expulsão do DIU ou SIU-LNG e a decisão de realizar esterilização entre as usuárias de implante. A taxa de continuação foi aproximadamente 95,0/100 mulheres/ano para os três métodos. Conclusões: A maioria das mulheres escolheu um LARC por ser mais prático e mais seguro e, após um ano, grande parte das mulheres continuou utilizando o método escolhido
Abstract: Objectives: To assess the main reasons for switching from methods requiring daily or monthly compliance to a Long Acting Reversible Contraceptive (LARC) method within a Brazilian cohort and to evaluate their satisfaction. Methods: Women of 18-50 years of age in use of different contraceptives and wishing to switch to a LARC method answered a questionnaire regarding their motivations for switching from their current contraceptive. Continuation rates were evaluated one year after method initiation. Sample size was calculated at 1,040 women. Clinical performance was evaluated by life table analysis. The cut-off date for analysis was May 23, 2013. Results: Overall, 1,167 women were interviewed; however, after one year of use, the medical records of 1,154 women were available for review. The main personal reason for switching, as reported by women, was "fear of becoming pregnant" while the medical reasons were nausea and vomiting and unscheduled bleeding. No pregnancies occurred during LARC use and the main reasons for discontinuation were expulsion (in the case of the IUD and LNG-IUS), and a decision to undergo surgical sterilization (in the case of the etonogestrel-releasing implant). Continuation rate was approximately 95.0/100 women/year for the three methods. Conclusions: Most women chose a LARC method for its safety and for practical reasons, and after one year of use most women continued with the method
Mestrado
Fisiopatologia Ginecológica
Mestra em Ciências da Saúde
APA, Harvard, Vancouver, ISO, and other styles
2

Ackermann, Camila Louise [UNESP]. "Uso do acetato de deslorelina como contraceptivo em gatos domésticos." Universidade Estadual Paulista (UNESP), 2012. http://hdl.handle.net/11449/98164.

Full text
Abstract:
Made available in DSpace on 2014-06-11T19:29:15Z (GMT). No. of bitstreams: 0 Previous issue date: 2012-01-20Bitstream added on 2014-06-13T20:19:14Z : No. of bitstreams: 1 ackermann_cl_me_botfmvz.pdf: 1838578 bytes, checksum: 9af8620d409cc960f6c129984e6ce9f1 (MD5)
Fundação de Amparo à Pesquisa do Estado de São Paulo (FAPESP)
O objetivo do presente estudo foi avaliar os efeitos do acetato de deslorelina como contraceptivo em felinos domésticos. Foram utilizados 15 gatos domésticos (10 fêmeas e 5 machos). As fêmeas foram acompanhadas através de citologias vaginais (CV), observação do comportamento sexual a cada 72 horas e dosagem de progesterona plasmática a cada 7dias. Quando em interestro/diestro as gatas foram submetidas à associação anestésica e um implante de acetato de deslorelina (Suprelorin® Peptech Animal Health Pty Limited, Austrália; 4,7 mg/animal) foi aplicado, permanecendo por 90 dias depois. Dez dias após a retirada do implante o estro e a ovulação foram induzidos com eCG e Hcg; três dias após as fêmeas foram submetidas à ovariosalpingohisterectomia. As tubas uterinas e útero foram lavados e o liquido recuperado foi observado para identificação e contagem de possíveis oócitos. Os oócitos foram isolados e corados para avaliação da viabilidade, os corpos lúteos quantificados e o cálculo da taxa de recuperação oocitária foi realizado.. Os ovários e útero foram avaliados quanto à histologia. Alterações histológicas foram descritas e as concentrações plasmáticas de progesterona foram submetidas a teste de normalidade e posteriormente submetidas ao Teste de Kolmogorov-Smirnov. Os demais resultados estão descritos em forma de média e desvio padrão. Os machos foram submetidos a duas avaliações andrológicas (M1 e M2) sempre precedidas de anestesia geral, imediatamente após a M2, um implante de acetato de deslorelina (Suprelorin® Peptech Animal Health Pty Limited, Austrália; 4,7 mg/animal) foi aplicado em cada gato. Após o inicio do tratamento foram realizadas mais três avaliações andrológicas (M3, M4 e M5) com intervalo de 30 dias. Após a M5, os implantes foram retirados e uma hemi orquiectomia realizada. Mais duas avaliações...
This study aimed evaluates the deslorelin acetate effects as a contraceptive in domestic felids. Fifteen domestic cats (10 females and 5 males) were used. The females were evaluated trough vaginal cytology (VC) and sexual behavior every 72 hours, and progesterone plasmatic concentration every 7 days. When in interestrous/diestrous the queens were submitted to an anesthetic protocol and receive one deslorelin acetate implant (Suprelorin® Peptech Animal Health Pty Limited, Australia; 4.7 mg/animal), remaining in treatment for 90 days. Teen days after the implant removal the estrous and ovulation were induced with eCG and hCG; three days after, all females were submitted to surgical castration. The oviduts and uterus were washed and the recovered liquid was observed for oocytes identification and count. The recovered oocytes were isolated and stained for viability evaluation, the corpus luteum were quantified and the oocyte recovery tax was calculated. Histologic evaluation was carried out in the ovary and uterus. The histologic evaluations were described and progesterone plasmatic concentration were submitted to Kolmogorov-Smirnov test. The remaining results were described as mean and standard deviation. Males were submitted to two andrological evaluations (M1 and M2), always preceded by anesthetic protocol. Immediately after M2, every cat receives one deslorelin acetate implant (Suprelorin® Peptech Animal Health Pty Limited, Australia; 4.7 mg/animal). After contraceptive treatment beginning, three andrological evaluations were conducted (M3, M4, and M5) with 30 days interval. After M5, the implants were removed and a hemiorquiectomy was performed. Other two andrological evaluations were performed (M6 and M7) with 30 days interval and at M7 the remaining testicle were removed. The testicles were submitted ...(Complete abstract click electronic access below)
APA, Harvard, Vancouver, ISO, and other styles
3

Ackermann, Camila Louise. "Uso do acetato de deslorelina como contraceptivo em gatos domésticos /." Botucatu : [s.n.], 2012. http://hdl.handle.net/11449/98164.

Full text
Abstract:
Orientador: Maria Denise Lopes
Banca: Carlos Roberto Teixeira
Banca: Marcelo Alcindo de Barros Vaz Guimarães
Resumo: O objetivo do presente estudo foi avaliar os efeitos do acetato de deslorelina como contraceptivo em felinos domésticos. Foram utilizados 15 gatos domésticos (10 fêmeas e 5 machos). As fêmeas foram acompanhadas através de citologias vaginais (CV), observação do comportamento sexual a cada 72 horas e dosagem de progesterona plasmática a cada 7dias. Quando em interestro/diestro as gatas foram submetidas à associação anestésica e um implante de acetato de deslorelina (Suprelorin® Peptech Animal Health Pty Limited, Austrália; 4,7 mg/animal) foi aplicado, permanecendo por 90 dias depois. Dez dias após a retirada do implante o estro e a ovulação foram induzidos com eCG e Hcg; três dias após as fêmeas foram submetidas à ovariosalpingohisterectomia. As tubas uterinas e útero foram lavados e o liquido recuperado foi observado para identificação e contagem de possíveis oócitos. Os oócitos foram isolados e corados para avaliação da viabilidade, os corpos lúteos quantificados e o cálculo da taxa de recuperação oocitária foi realizado.. Os ovários e útero foram avaliados quanto à histologia. Alterações histológicas foram descritas e as concentrações plasmáticas de progesterona foram submetidas a teste de normalidade e posteriormente submetidas ao Teste de Kolmogorov-Smirnov. Os demais resultados estão descritos em forma de média e desvio padrão. Os machos foram submetidos a duas avaliações andrológicas (M1 e M2) sempre precedidas de anestesia geral, imediatamente após a M2, um implante de acetato de deslorelina (Suprelorin® Peptech Animal Health Pty Limited, Austrália; 4,7 mg/animal) foi aplicado em cada gato. Após o inicio do tratamento foram realizadas mais três avaliações andrológicas (M3, M4 e M5) com intervalo de 30 dias. Após a M5, os implantes foram retirados e uma hemi orquiectomia realizada. Mais duas avaliações ...(Resumo completo, clicar acesso eletrônico abaixo)
Abstract: This study aimed evaluates the deslorelin acetate effects as a contraceptive in domestic felids. Fifteen domestic cats (10 females and 5 males) were used. The females were evaluated trough vaginal cytology (VC) and sexual behavior every 72 hours, and progesterone plasmatic concentration every 7 days. When in interestrous/diestrous the queens were submitted to an anesthetic protocol and receive one deslorelin acetate implant (Suprelorin® Peptech Animal Health Pty Limited, Australia; 4.7 mg/animal), remaining in treatment for 90 days. Teen days after the implant removal the estrous and ovulation were induced with eCG and hCG; three days after, all females were submitted to surgical castration. The oviduts and uterus were washed and the recovered liquid was observed for oocytes identification and count. The recovered oocytes were isolated and stained for viability evaluation, the corpus luteum were quantified and the oocyte recovery tax was calculated. Histologic evaluation was carried out in the ovary and uterus. The histologic evaluations were described and progesterone plasmatic concentration were submitted to Kolmogorov-Smirnov test. The remaining results were described as mean and standard deviation. Males were submitted to two andrological evaluations (M1 and M2), always preceded by anesthetic protocol. Immediately after M2, every cat receives one deslorelin acetate implant (Suprelorin® Peptech Animal Health Pty Limited, Australia; 4.7 mg/animal). After contraceptive treatment beginning, three andrological evaluations were conducted (M3, M4, and M5) with 30 days interval. After M5, the implants were removed and a hemiorquiectomy was performed. Other two andrological evaluations were performed (M6 and M7) with 30 days interval and at M7 the remaining testicle were removed. The testicles were submitted ...(Complete abstract click electronic access below)
Mestre
APA, Harvard, Vancouver, ISO, and other styles
4

Nyeko, Moini Brian Anyau. "Hormonal Contraceptives for men." Thesis, Uppsala universitet, Institutionen för farmaceutisk biovetenskap, 2018. http://urn.kb.se/resolve?urn=urn:nbn:se:uu:diva-422360.

Full text
Abstract:
Background: Contraceptives for men has existed for centuries. However, the only contraceptives available for men are condoms, withdrawal during sexual intercourse or undergoing Vas occlusion. The issues currently with these methods are that many couples are not comfortable with using condoms and vasectomy is a non-reversible contraceptive as it requires surgery. Currently, only research has been made with regards to hormonal contraceptives for men. The basis for hormonal contraceptives for men is that it disturbs hypothalamic-pituitary–gonadal axis, by suppressing GnRH, LH and FSH in order to suppress spermatogenesis. The substances that have been clinically tested as a potential hormonal contraceptive for men are androgens, androgens together progestins and synthetic androgens. Aim: The aim of this thesis was to examine the effectiveness of the substances that have been used in past and recent clinical trials and the adverse drug reactions/effects. Method: Results from the clinical trials were collected through PubMed with regards to preordained criteria, which resulted in 18 scientific articles being used in the results. Results: Overall, the results showed that the majority of substances used in previous and recent clinical trials are effective in suppressing spermatogenesis. The results also showed that a majority of substances used in previous and recent clinical trials had severe adverse drug effects severe amongst the participants. Discussion and Conclusion:  In summary, the research shows that amongst the substances used in recent and current clinical trials, that synthetic androgens have the best potential as a hormonal contraceptive for men with regards to effectiveness and adverse drug effects.
APA, Harvard, Vancouver, ISO, and other styles
5

Kauki, Tom. "Quality of the combined oral contraceptive pill (0.15mg levonorgestrel and 0.03mg ethinylestradiol) in the private retail pharmacies of Nyeri Town, Kenya. Results from a postmarket quality study." University of the Western Cape, 2015. http://hdl.handle.net/11394/4691.

Full text
Abstract:
Magister Pharmaceuticae - MPharm
Background: The effectiveness of the combined oral contraceptive pill as a family planning method is dependent on its quality. The quality of medicines on the healthcare market is established through postmarket quality studies. Methods: The quality of the combined oral contraceptive pill was established through the collection of samples from 17 (62%) private retail pharmacies in the Nyeri town of Kenya. Their quality was then determined through the assay of content of levonorgestrel and ethinylestradiol and the levonorgestrel dissolution test at the National Quality Control Laboratory. Findings: 13 of the 17 pharmacies were licensed with the Pharmacy and Poisons Board while 4 were unlicensed. Femiplan® was available in all the 17 pharmacies while Microgynon® was available in only 4 pharmacies. 17 samples of Femiplan® and 4 samples of Microgynon® were collected. None of the samples was counterfeit or falsely labeled. All the samples passed the assay of content of levonorgestrel and ethinylestradiol and the levonorgestrel dissolution test. Conclusion: Notwithstanding the fact this study provides a snapshot in time, it is reasonable to conclude that the combined oral contraceptive pill (0.15mg levonorgestrel and 0.03mg ethinylestradiol) in the Nyeri town of Kenya private retail pharmacies is of the right quality with respect to the quality tests of assay of content of levonorgestrel and ethinylestradiol and the levonorgestrel dissolution test.
APA, Harvard, Vancouver, ISO, and other styles
6

Mothogoane, Kagiso Andronicca. "Challenges faced by female teenagers in accessing contraceptives at Bylodrift Clinic, Malatane Village, Capricorn District of Limpopo Province." Thesis, University of Limpopo, 2018. http://hdl.handle.net/10386/2328.

Full text
Abstract:
Thesis (M. A.) -- University of Limpopo, 2018
The study sought to provide deeper understanding on access to contraceptives by female teenagers. The aim of this study was to explore the challenges faced by female teenagers in accessing contraceptives at Byldrift Clinic, Malatane Village, Capricorn District of Limpopo Province. Qualitative research method was applied in the study. The study utilised case study research design. Purposive sampling was used to select participants. Face to face interviews were conducted with ten (10) female teenagers. The age of participants ranges from 15 years to 19 years. Thematic Analysis was used to analyse data. The negative attitude of healthcare providers was cited as a challenge for teenagers accessing contraceptives, however other participants cited positive attitude of healthcare providers. The experience of side effects, parents and partners were cited as major challenges experienced while using contraceptives. The problem of inaccessibility remains a challenge in public health facilities; participants reported long waiting times, long distance to get to the clinic, shortage of staff, lack of confidentiality and lack of proper infrastructure. Most participants indicated that they discuss contraception with their peers, therefore peer influence remains an influential factor in accessing contraceptives. The study recommended that healthcare providers should give the effectiveness rate of the contraceptive method and ways to manage side effects, health facilities need to be more user friendly and that operating hours should be convenient to teenagers who are still schooling. This is evident that young women face challenges in accessing contraceptives. Keywords: Access, challenge, contraceptives, teenagers
APA, Harvard, Vancouver, ISO, and other styles
7

Hedner, Benjamin, Karl Irgens Eliasson, and Pär Isaksson. "Factors affecting Women when choosing Contraceptives." Thesis, Karlstad University, Karlstad University, 2004. http://urn.kb.se/resolve?urn=urn:nbn:se:kau:diva-1183.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Amaral, Douglas Sousa. "Avaliação de formulações contraceptivas por parâmetros hemostáticos, vasoativos e inflamatórios em cultura de células endoteliais humanas." Universidade de São Paulo, 2015. http://www.teses.usp.br/teses/disponiveis/60/60135/tde-25092015-143858/.

Full text
Abstract:
Contraceptivos orais combinados (COCs) são largamente utilizados e bem aceitos para se obter a contracepção. Estima-se que mais de 100 milhões de mulheres ao redor do mundo fazem uso deste método contraceptivo. Embora seja alcançada a contracepção, estas usuárias estão predispostas ao desenvolvimento de tromboembolismo venoso (TEV) ou arterial (TEA), e ao desenvolvimento de aterosclerose, em virtude da alteração hemostática causada pela dose de estrógeno e tipo de progesterona utilizada nas formulações. Como forma de obter uma formulação dita \"ideal\" e na esperança de que os efeitos adversos que podem ocorrer em detrimento da composição da formulação contraceptiva sejam minimizados, a literatura aponta um contraceptivo recentemente lançado, cuja composição contém o Valerato de Estradiol (chamado de estrógeno natural pela indústria farmacêutica) como componente estrogênico e o Dienogest como progesterona sintética, integrando o grupo dos assim classificados novos progestágenos. OBJETIVO: Dentro do contexto que acima apresentamos, o projeto de pesquisa teve como objetivo avaliar duas formulações contraceptivas, através de um estudo experimental comparativo, onde como grupo controle utilizamos o clássico Levonorgestrel (LVG) e Etinilestradiol (EE), para compará-lo com o novo progestágeno lançado no mercado brasileiro em 2011, composto por Dienogest (DNG) e Valerato de estradiol (17? Estradiol - metabólito ativo) - ambos medicamentos isolados e em mistura, representados por MIX I (LVG+EE) e MIX II (DNG+17?), respectivamente. Pelo fato de pouco se saber sobre os efeitos deste novo progestágeno sobre os fatores vasoativos, hemostáticos e inflamatórios, propusemos aqui trabalhar com cultura de células endoteliais extraídas de cordão umbilical humano, estimulá-las com agente inflamatório LPS e/ou TNF? para posteriormente dosar os seguintes fatores: em Célula Endotelial de Veia Umbilical Humana (HUVEC) - moléculas de adesão VCAM-I, ICAM-I e E-Selectina (sobrenadante e superfície celular de HUVEC); fatores vasoativos derivados do endotélio (NO, Prostaglandina PGE2 e Endotelina ET-1 - sobrenadante) e citocinas pró-inflamatórias IL-1? e IL-6 no sobrenadante. Em Célula Endotelial de Artéria Humana (HAEC): Fator Tecidual. Os medicamentos reduziram a expressão de moléculas de adesão no sobrenadante e na superfície celular, regularam a produção de fatores vasoativos derivados do endotélio, reduziram a produção de citocinas pró-inflamatórias e reduziram também a expressão de fator tecidual, de maneira preventiva e terapêutica. A mistura dos contraceptivos representada por MIX I e MIX II apresentou diferenças significativas quando comparadas aos demais grupos de estudo e MIX II apresentou maior efetividade na redução de alguns fatores aqui estudados, conferindo uma proteção endotelial. Desta maneira, podemos concluir que o novo progestágeno lançado no mercado brasileiro apresentou efeitos antitrombóticos e anti-inflamatórios, por reduzir de maneira significativa os níveis de moléculas de adesão, fatores vasoativos, fatores pró-inflamatórios e fator hemostático
Combined oral contraceptives (COCs) are widely used and well accepted to provide contraception. It\'s estimated that over 100 million women around the world make use of this contraceptive method. Although contraception is achieved, these users are predisposed to developing venous thromboembolism or arterial and development of atherosclerosis due to the change caused by the hemostatic dose of estrogen and progestin type used in the formulations. In order to get a said formulation \"correct\" and hoping that the adverse effects that may occur at the expense of the contraceptive formulation composition are minimized, the literature indicates a contraceptive recently launched, whose composition contains Estradiol valerate (called natural estrogen by the pharmaceutical industry) as estrogen component and the Dienogest as synthetic progesterone, integrating the group of so classified new progestins. OBJECTIVE: Within the context that we present above, the research project aimed to evaluate two contraceptive formulations, through a comparative experimental study, where as the control group used the classic Levonorgestrel (LVG) and ethinylestradiol (EE), to compare it with the new progestin released in Brazil in 2011, composed of Dienogest (DNG) and estradiol valerate (17? Estradiol - active metabolite) - both alone and in combination medications, represented by MIX I (LVG plus EE) and MIX II (DNG plus 17?), respectively. \'Cause little is known about the effects of the progestogen on the new vasoactive factors, hemostatic and inflammatory proposed here work with cultured endothelial cells derived from human umbilical cord stimulus them with LPS inflammatory agent and / or TNF? to further quantitate the following factors: HUVEC (Human Umbilical Vein Endothelial Cell) - adhesion molecules VCAM-I, ICAM-I and E-selectin (supernatant and cell surface); endothelium-derived vasoactive factors (NO, PGE2 and Endothelin ET-1 - culture supernatant) and pro-inflammatory cytokines as IL-1? and IL-6 in the supernatant. HAEC (Human Arterial Endothelial Cell): Tissue factor on primary cell culture of umbilical cord artery. The drugs reduced the expression of adhesion molecules in the supernatant and the cell surface reduced the production of endothelium-derived vasoactive factors, regulated the production of cytokines proinflammatory and also reduced the expression of tissue factor, preventive and therapeutic way. The mixture of contraceptives represented by MIX MIX I and II showed significant differences when compared to the other study groups and MIX II showed greater effectiveness in reducing some factors studied here, giving an endothelial protection. Thus, we can conclude that the new progestogen released in Brazil showed antithrombotic effects and anti-inflammatory, to reduce significantly the levels of adhesion molecules, vasoactive factors, proinflammatory factors and hemostatic factor.
APA, Harvard, Vancouver, ISO, and other styles
9

Ezeanolue, Echezona E., Juliet Iwelunmor, Ibitola Asaolu, Michael C. Obiefune, Chinenye O. Ezeanolue, Alice Osuji, Amaka G. Ogidi, et al. "Impact of male partner's awareness and support for contraceptives on female intent to use contraceptives in southeast Nigeria." BioMed Central Ltd, 2015. http://hdl.handle.net/10150/610299.

Full text
Abstract:
BACKGROUND: Despite the growing body of evidence on use of modern contraceptives among women in sub-Saharan African countries, little is known about the broader context in which female decision-making concerning contraceptive use occurs, particularly the role of their male partners' awareness and support of modern contraceptives. METHODS: We conducted a cross-sectional survey of 2468 pregnant women and their male partners enrolled in the Healthy Beginning Initiative (HBI), an intervention to increase HIV testing among pregnant women in Enugu, southeast Nigeria. The aims of this study were to determine: 1) male partners' awareness of, and support for, female contraceptive methods, and 2) influence of male partners' contraceptive awareness and support on pregnant women's expressed desire to use contraception. We used logistic regression models to examine the association between male partners' awareness and support of modern contraceptives on their spouses' desire to use contraceptives. RESULTS: Men's awareness of, and support for, use of modern contraceptives were significantly associated with their female partners' desire to use contraception. A majority of the men who were aware of modern contraceptives (66.5 %) and those who supported their spouses' use of contraception (72.5 %) had partners who expressed a desire to use contraception. Men who were aware of female contraception were 3 times more likely to have spouses who desired to use contraception (AOR = 3.17, 95 % C.I: 2.70-3.75). In addition, men who showed support for their spouses' use of contraception were over 5 times more likely to have spouses who indicated a desire to use contraception (AOR = 5.76, 95 % C.I: 4.82-6.88). Living in a household of 5 or more people (AOR = 1.45, 95 % C.I: 1.23-1.72) and residing in an urban area (AOR = 0.81, 95 % C.I: 0.67-0.97) were also significantly associated with women's expressed desire to use modern contraception. CONCLUSION: Men's awareness of, and support for, use of modern contraceptives were markedly associated with their spouses' desire to use contraception. This underscores the need for men's involvement in programs that seek to address women's uptake of contraception in low and middle income countries.
APA, Harvard, Vancouver, ISO, and other styles
10

Dallman, Rebecca. "Disparities in the Use of Emergency Contraceptives." VCU Scholars Compass, 2007. http://hdl.handle.net/10156/2056.

Full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Books on the topic "Contraceptives"

1

(Organization), Family Health International. Oral contraceptives: Contraceptive technology. Research Triangle Park, NC: Family Health International, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
2

Retailing, Corporate Intelligence on, ed. Contraceptives. London: CIR, 1998.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
3

Group, Mintel International, ed. Contraceptives. London: Mintel International Group, 1999.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
4

Health, Botswana Ministry of, ed. Managing family planning commodities and drugs in Botswana. [Gaborone] Botswana: Ministry of Health, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
5

Kleinman, R. L. Directory of hormonal contraceptives. 3rd ed. London: International Planned Parenthood Federation, 1996.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
6

Willis, Judith. Comparing contraceptives. [Rockville, Md: Dept. of Health and Human Services, Public Health Service, Food and Drug Administration, Office of Public Affairs (5600 Fishers Lane, Rockville 20857)], 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
7

Affandi, Biran. Implantable contraceptives. Jakarta: National Family Planning Coordinating Board, 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
8

Willis, Judith. Comparing contraceptives. [Rockville, Md: Dept. of Health and Human Services, Public Health Service, Food and Drug Administration, Office of Public Affairs, 1989.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
9

K, Sood S. Herbal contraceptives. Dehradun: International Book Distributors, 2011.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
10

Willis, Judith. Comparing contraceptives. [Rockville, Md: Dept. of Health and Human Services, Public Health Service, Food and Drug Administration, Office of Public Affairs (5600 Fishers Lane, Rockville 20857)], 1991.

Find full text
APA, Harvard, Vancouver, ISO, and other styles
More sources

Book chapters on the topic "Contraceptives"

1

Gudermann, Thomas. "Contraceptives." In Encyclopedia of Molecular Pharmacology, 1–9. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-21573-6_43-1.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Gudermann, Thomas. "Contraceptives." In Encyclopedia of Molecular Pharmacology, 483–90. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-57401-7_43.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Shoupe, Donna. "Injectable Contraceptives and Contraceptive Vaginal Rings." In Clinical Perspectives in Obstetrics and Gynecology, 144–57. New York, NY: Springer New York, 1993. http://dx.doi.org/10.1007/978-1-4612-2730-4_13.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

d’Arcangues, Catherine, and Rachel C. Snow. "Injectable Contraceptives." In Fertility Control — Update and Trends, 121–49. Berlin, Heidelberg: Springer Berlin Heidelberg, 1999. http://dx.doi.org/10.1007/978-3-642-86696-8_6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Nelson, Anita L., and Jennefer Russo. "Barrier Contraceptives." In The Handbook of Contraception, 181–202. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-20185-6_11.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Natavio, Melissa F. "Emergency Contraceptives." In The Handbook of Contraception, 203–13. Cham: Springer International Publishing, 2016. http://dx.doi.org/10.1007/978-3-319-20185-6_12.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Shoupe, Donna. "Barrier Contraceptives." In The Handbook of Contraception, 147–77. Totowa, NJ: Humana Press, 2006. http://dx.doi.org/10.1007/978-1-59745-150-5_10.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Shoupe, Donna, and Daniel R. Mishell. "Oral Contraceptives." In The Handbook of Contraception, 13–43. Totowa, NJ: Humana Press, 2006. http://dx.doi.org/10.1007/978-1-59745-150-5_2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Shoupe, Donna. "Oral Contraceptives." In The Handbook of Contraception, 45–66. Totowa, NJ: Humana Press, 2006. http://dx.doi.org/10.1007/978-1-59745-150-5_3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Schickler, Robyn, and Jasmine Patel. "Barrier Contraceptives." In The Handbook of Contraception, 163–81. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-46391-5_9.

Full text
APA, Harvard, Vancouver, ISO, and other styles

Conference papers on the topic "Contraceptives"

1

Gayatri, Maria. "The Use of Modern Contraceptives among Poor Women in Urban Areas in Indonesia." In The 7th International Conference on Public Health 2020. Masters Program in Public Health, Universitas Sebelas Maret, 2020. http://dx.doi.org/10.26911/the7thicph.03.27.

Full text
Abstract:
ABSTRACT Background: Poverty in urban areas is a complex problem for the development of human resources, including the control of population numbers. This study aimed to determine the factors influencing the use of modern contraceptives in urban areas among poor women in Indonesia. Subjects and Method: This was a cross-sectional study conducted in rural areas in Indonesia. Total of 3,249 women aged 15-49 years who were poor and live in urban areas in Indonesia were enrolled in this study. The dependent variable was the use of modern contraceptives. The independent variables were husband’s work status, desire to have children, age, number of children living with, health insurance, women education, and internet use. Data were collected from the 2017 Indonesian Demographic and Health Survey (IDHS). Data were analyzed using a multiple logistic regression. Results: The use of modern contraceptives among poor urban women in Indonesia reached 59.8%. Women living with actively working husband (OR = 2.64; 95% CI = 1.43 to 4.88; p<0.001), desire to have children (OR = 2.24; 95% CI = 1.87 to 2.67; p<0.001), aged 20-34 years (OR = 1.68; 95% CI = 1.07 to 2.65; p<0.001), the number of children living 3 or more (OR = 1.23; 95% CI = 1.03 to 1.47; p<0.001), and having health insurance (OR = 1.19; 95% CI = 1.03 to 1.39; p<0.001) were more likely to use modern contraceptive methods. Meanwhile, women who are highly educated and women who actively use the internet were more likely to not use modern contraceptives. Conclusion: The dominant factor affecting is the husband’s work status and the desire to have children. Health insurance owned by poor women greatly influences the use of modern contraceptives. It is recommended to improve communication, information and education (IEC), counseling, and access to contraceptive services to continue to be carried out in urban poor areas in Indonesia. Keywords: modern contraception, poor, urban, family planning, logistic regression. Correspondence: Maria Gayatri. Center for Family Planning and Family Welfare Research and Development, National Population and Family Planning Agency. Jl. Permata no. 1, Halim Perdana Kusuma, East Jakarta, Indonesia. Email: maria.gayatri.bkkbn@gmail.com. Mobile: 081382580297 DOI: https://doi.org/10.26911/the7thicph.03.27
APA, Harvard, Vancouver, ISO, and other styles
2

Farag, A. M., S. F. Bottoms, E. F. Mammen, M. Hosni, and A. Ali. "EFFECT OF ORAL CONTRACEPTIVES ON HEMOSTASIS." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1644283.

Full text
Abstract:
Retrospective statistical epidemiological studies have suggested a possible association between the ingestion of oral contraceptives (OC) and thromboembolic disease. Past analyses of the coagulation system have yielded controversial informationWe studied a cross section of 131 women taking different kinds of OC and 36 controls for changes in hemostasis. No significant differences were noted in the levels of fibrino- peptide A (RIA), platelet factor 4, 8 thromboglobulin (RIA), fibrinogen (Multistat III (MCA), clottable), antithrombin III (MCA, S-2238), α2 antiplasmin (MCA, S-2251), pre-kallikrein (MCA, S-2302) and fibronectin (MCA, immune turbi-dometric). However, plasminogen (MCA, S-2251) and protein C antigen (Laurell) levels were significantly elevated (p < 0.001 and p < 0.01), respectively)Canonical correlation analysis was used to examine correlations between hemostasis parameters measured and clinical risk factors, such as age, parity, weight, smoking, family history for thromboembolic diseases and estrogen-progesterone dose. There was a significantly negative correlation between family history for thromboembolisms and antithrombin III levels (p < 0.01). A positive correlation existed between obesity and fibrinogen and fibronectin levels (p < 0.001 for both). The hemostasis data seem to suggest that OC use does not introduce an imbalance in the hemostasis system which fosters "hypercoagulability", and that, if at all, possibly other risk factors determine the incidence of thromboembolisms in OC users. It is suggested that caution be exercised in the use of OCs in patients with a history of thromboembolic diseases and with obesity
APA, Harvard, Vancouver, ISO, and other styles
3

Afriyanti, Neta, Eti Poncorini Pamungkasari, and Hanung Prasetya. "The Effect of Hormonal Contraceptive Use on the Risk of Depression in Women of Reproductive Age: Evidence from Gunungkidul, Yogyakarta." In The 7th International Conference on Public Health 2020. Masters Program in Public Health, Universitas Sebelas Maret, 2020. http://dx.doi.org/10.26911/the7thicph.03.121.

Full text
Abstract:
ABSTRACT Background: Estrogen and progesterone hormones have been hypothesized to play a role in the cause of depressive symptoms in female. Clinical studies have indicated that changes in estrogen levels may trigger depressive episodes among women at risk for depression. A previous study found that use of combined oral contraceptives among women who previously had experienced emotional adverse effects resulted in mood deterioration and changes in emotional brain reactivity. This study aimed to examine the effect of hormonal contraceptive use on the risk of depression in women of reproductive age. Subjects and Method: A cross-sectional study was carried out in Gunungkidul, Yogyakarta. A sample of 200 women of reproductive age was selected by purposive sampling. The dependent variable was depression symptom. The independent variables were age, education, duration of contraceptive use, type of contraceptive use, employment, and family income. Depression symptom was measured by Beck Depression Inventory II (BDI II). The other variables were collected by questionnaire. The data were analyzed by a multiple logistic regression run on Stata 13. Results: Depression symptoms increased with hormonal contraception (OR= 3.74; 95% CI= 1.61 to 8.65; p= 0.001) and duration of contraceptive use ≥36 months (OR= 6.33; 95% CI= 2.36 to 16.97; p <0.001). Depression symptoms decreased with age ≥29 years (OR= 0.12; 95% CI= 0.04 to 0.34; p <0.001), family income ≥Rp 1,571,000 (OR= 0.10; 95% CI= 0.04 to 0.24; p <0.001), education ≥Senior high school (OR= 0.18; 95% CI= 0.07 to 0.45; p<0.001), and working at home (OR= 0.37; 95% CI= 0.16 to 0.83; p= 0.016). Conclusion: Depression symptoms increase with hormonal contraception and duration of contraceptive use ≥36 months. Depression symptoms decrease with age ≥29 years, family income ≥Rp 1,571,000, education ≥Senior high school, and working at home. Keywords: hormonal contraceptive, depression Correspondence: Neta Afriyanti. Masters Program in Public Health, Universitas Sebelas Maret. Jl. Ir. Sutami 36 A, Surakarta 57126, Central Java. Email: neta.friyanti16@gmail.com DOI: https://doi.org/10.26911/the7thicph.03.121
APA, Harvard, Vancouver, ISO, and other styles
4

Mendoza, MD Molina, C. Palomar Fernandez, C. Perez Menénedez-Conde, B. Montero Llorente, L. García Basas, and T. Bermejo Vicedo. "PS-072 Oral contraceptives and risk of thromboembolic events." In 22nd EAHP Congress 22–24 March 2017 Cannes, France. British Medical Journal Publishing Group, 2017. http://dx.doi.org/10.1136/ejhpharm-2017-000640.578.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Hurst, Noémie, Matthias Pellek, Patricia N. Sidharta, and Jasper Dingemanse. "Pharmacokinetics and safety of concomitant macitentan and hormonal contraceptives." In Annual Congress 2015. European Respiratory Society, 2015. http://dx.doi.org/10.1183/13993003.congress-2015.pa2111.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Kulik, Marco Antonio, Rosa Maria Eid Weiler, Danilo Rodrigues de Oliveira, Juliana Teixeira, and Maria Sylvia de Souza Vitalle. "GENGIVAL BLEEDING IN ADOLESCENTS WITH USE OF ORAL CONTRACEPTIVES." In IV International Symposium Adolescence(s) and II Education Forum. Universidade Federal de São Paulo, 2018. http://dx.doi.org/10.22388/2525-5894.2018.0031.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Ningrum, Sri Setiyo, Dono Indarto, and Mahendra Wijaya. "EMPLOYMENT STATUS, FAMILY INCOME, CONTRACEPTIVE AVAILABILITY, AND THEIR EFFECTS ON THE USE OF LONG TERM CONTRACEPTIVES IN SUKOHARJO, CENTRAL JAVA." In THE 2ND INTERNATIONAL CONFERENCE ON PUBLIC HEALTH. Masters Program in Public Health, Sebelas Maret University, 2017. http://dx.doi.org/10.26911/theicph.2017.127.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Satriyandari, Yekti, Yushe Quasimah, and Yuliana Umrotun. "The Use of Contraceptives in Commercial Sex Workers in Yogyakarta." In International Conference on Health and Medical Sciences (AHMS 2020). Paris, France: Atlantis Press, 2021. http://dx.doi.org/10.2991/ahsr.k.210127.033.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Machin, S. J., I. J. Mackie, K. Walshe, and M. D. Gillmer. "HAEMOSTATIC CHANGES INDUCED BY TWO LOW DOSE TRIPHASIC ORAL CONTRACEPTIVES." In XIth International Congress on Thrombosis and Haemostasis. Schattauer GmbH, 1987. http://dx.doi.org/10.1055/s-0038-1643825.

Full text
Abstract:
The haemostatic system was investigated in 26 women taking cyclically administered triphasic combined oral contraceptives for the first time during their first six cycles. Fourteen women received Logynon (mean dose 32.4μg ethinyloestradiol, 92pg progestagen) and 12 received SHD 415G (Schering) which contains a mean dosage of 32.4μg ethinyloestradiol and 78pg gestodene, a recently developed progesterone. The Logynon group showed a significant increase (p<0.005) in fibrinogen (pre-mean 284.4 g/1; after 1 cycle 347.3 g/1, after 6 cycles 318.6 g/1) , factor VII (65.8 u/1 to 73.9 u/1 to 83.2 u/1), factor XII (1.74 u/1 to 2.41 u/1, to 2.25 u/1), plasminogen (100.9 u/1 to 135.1 u/1 to 126.3 u/1); decrease in ATIII (115.9 u/1 to 103.1 u/1 to 93.4 u/1) but no significant change in factor X (98.4 u/1 to 108.9 u/1 to 102.4) or protein C (0.85 u/1 to 0.88 u/1 to 0.94 u/1) activity. The SHD 415G group showed similar changes with an increase in fibrinogen (247.9 g/1 to 330.8 g/1 to 373 .1 g/1), factor VII (63.1 u/1 to 73.1 u/1 to 90.3 u/1, factor X (98.3 u/1 to 112.0 u/1 to 124.4 u/1), factor XII (1.46 u/1, to 1.93 u/1, to 2.03 u/1), plasminogen (110.8 u/1 to 125.4 u/1 to 136.7 u/1); decrease in ATIII (113.1 u/1 to 96.3 u/1 to 89.7 u/1), but no change in protein C (0.84 u/1 to - 0.78 u/1 to 0.85 u/1) activity. These changes were apparent after the first cycle of therapy and the differences were maintained over the six cycle period. There was no increase in protein C activity despite changes in the other vitamin K dependent proteins factors VII and X. Both low oestrogen dose triphasic pills caused similar prothrombotic changes which were not modified by the new progesterone, gestodene.
APA, Harvard, Vancouver, ISO, and other styles
10

Silva, Elisangela Da. "TROMBOSE VENOSA PROFUNDA EM MULHERES PELO USO DE CONTRACEPTIVOS ORAIS: UMA REVISÃO NARRATIVA." In II Congresso Brasileiro de Hematologia Clínico-laboratorial On-line. Revista Multidisciplinar em Saúde, 2022. http://dx.doi.org/10.51161/hematoclil/39.

Full text
Abstract:
Introdução: A trombose é uma doença causada por obstrução de um vaso sanguíneo, decorrente de coágulos, uma vez que, 90% dos casos acometem membros inferiores, caracterizando-se assim, em Trombose Venosa Profunda, sendo esta, considerada a terceira maior causa de doença vascular que na maior parte das vezes está relacionada ao uso de contraceptivos hormonais por mulheres em idade fértil, apresentando, alta morbimortalidade e complicações como síndrome pós-trombótica e até mesmo embolia pulmonar e quanto a sua relação ao uso desses hormônios (estrogênios e progesteronas), o risco de trombose ocorre devido o mecanismo de primeira passagem pelo fígado, uma vez que, os fatores coagulantes e anticoagulantes são sintetizados nesse órgão, podendo assim alterar a hemostasia vascular. Objetivo: Demonstrar a relação entre trombose venosa profunda e o uso de contraceptivos orais. Material e métodos: Trata-se de uma revisão de literatura narrativa, realizada em janeiro de 2022, que utilizou as bases de dados do Google Acadêmico e LILACS, através das palavras chave, deep venous thrombosis and contraceptives, entre os anos de 2018 e 2022, optou-se por estudos brasileiros, em idioma português e disponíveis para download. Resultados: Dos 77 estudos encontrados, 03 destes foram selecionados, por apresentarem informações relevantes quanto ao objetivo do estudo. Observou-se ao longo dos anos, uma redução nas doses e desenvolvimento de novos contraceptivos, com intuito de eliminar o risco de trombose, no entanto, houve apenas uma redução na incidência e em análise, estudos apontam que o evento trombótico relacionado ao uso de anticoncepcionais é baixo, visto que, estimativas apontam a ocorrência entre 8 a 10/10.000 mulheres expostas por anos e quanto aos fatores de risco um estudo demonstrou que mulheres predispostas a desenvolverem a doença ao uso dessa classe de medicamentos é aumentado naquelas com histórico de trombose venosa superficial ou com idade ≥ a 50 anos. Conclusão: Comprovadamente o uso de contraceptivos orais podem causar trombose venosa profunda e apesar de sua baixa ocorrência, o risco é eminente, em consideração a isso, é de grande importância a implementação de outros métodos contraceptivos, principalmente no âmbito do SUS, que apresentem melhor custo benefício e acessibilidade.
APA, Harvard, Vancouver, ISO, and other styles

Reports on the topic "Contraceptives"

1

Kelsey, Jennifer L. Oral Contraceptives and Bone Health in Female Runners. Fort Belvoir, VA: Defense Technical Information Center, October 2004. http://dx.doi.org/10.21236/ada435728.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Kelsey, Jennifer L. Oral Contraceptives and Bone Health in Female Runners. Fort Belvoir, VA: Defense Technical Information Center, October 2005. http://dx.doi.org/10.21236/ada443584.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Kelsey, Jennifer L. Oral Contraceptives and Bone Health in Female Runners. Fort Belvoir, VA: Defense Technical Information Center, October 2001. http://dx.doi.org/10.21236/ada400469.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Kelsey, Jennifer L. Oral Contraceptives and Bone Health in Female Runners. Fort Belvoir, VA: Defense Technical Information Center, October 2002. http://dx.doi.org/10.21236/ada415838.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Kelsey, Jennifer L. Oral Contraceptives and Bone Health in Female Runners. Fort Belvoir, VA: Defense Technical Information Center, October 2003. http://dx.doi.org/10.21236/ada422917.

Full text
APA, Harvard, Vancouver, ISO, and other styles
6

Burton, Jennifer L., James D. Westervelt, and Stephen Ditchkoff. Simulation of Wild Pig Control via Hunting and Contraceptives. Fort Belvoir, VA: Defense Technical Information Center, October 2013. http://dx.doi.org/10.21236/ada590472.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Biddlecom, Ann, Taylor Riley, Jacqueline E. Darroch, Elizabeth A. Sully, Vladimíra Kantorová, and Mark C. Wheldon. Future Scenarios of Adolescent Contraceptive Use, Cost and Impact in Developing Regions. Guttmacher Institute, August 2018. http://dx.doi.org/10.1363/2018.29732.

Full text
Abstract:
Key Points This report presents scenarios of adolescent contraceptive use through 2030 to highlight the potential impact and costs associated with overall increased contraceptive use among adolescents and an increased use of long-acting, reversible contraceptives (LARCs), specifically. Under a scenario that assumes the most likely level of modern contraceptive use to be reached in a particular year (median values of probabilistic projections), the number of adolescent women using modern contraceptives in developing regions would reach 19.8 million in 2030, and 57% of adolescent women would have their need for modern contraception met. The total annual cost of services in 2030 for the projected 19.8 million modern method users would be an estimated $310 million. The cost would be lower, at $275 million, if 20% of adolescent women using short-acting methods were to choose LARCs. An estimated 7.1 million unintended pregnancies would be averted under this scenario. Because LARCs are highly effective, a shift toward use of these methods would avert an additional 300,000 unintended pregnancies. Under a scenario with accelerated growth in modern contraceptive use among adolescent women in developing regions, the number of modern method users would reach 27.1 million in 2030, and the proportion of adolescent women whose need for modern contraception would be met would rise to 79%. Contraceptive services for the 27.1 million modern method users in 2030 would cost an estimated $412 million. The cost would drop to $365 million under an assumption of increased LARC use. In 2030, an estimated 9.6 million unintended pregnancies would be averted under this accelerated growth scenario, and an additional 400,000 unintended pregnancies would be averted with a shift to LARC use.
APA, Harvard, Vancouver, ISO, and other styles
8

Register, Thomas. Oral Contraceptives Use by Young Women Reduces Peak Bone Mass. Fort Belvoir, VA: Defense Technical Information Center, December 2002. http://dx.doi.org/10.21236/ada417286.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Register, Thomas. Oral Contraceptives Use by Young Women Reduces Peak Bone Mass. Fort Belvoir, VA: Defense Technical Information Center, September 2000. http://dx.doi.org/10.21236/ada390773.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Register, Thomas. Oral Contraceptives Use by Young Woman Reduces Peak Bone Mass. Fort Belvoir, VA: Defense Technical Information Center, September 1999. http://dx.doi.org/10.21236/ada376507.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the extended bibliographies on the topic 'Contraceptives' for particular source types:
Journal articles Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography